Notes: Oct. 28, 2019 -- Neuralstem, Inc. (NASDAQ:CUR), announces that the company has changed its name to Seneca Biopharma, Inc. The Company anticipates that the common stock, which trades on the Nasdaq Capital Market will cease trading under the ticker symbol “CUR” and will commence trading under the new ticker symbol “SNCA.” Along with the ticker change, the Company’s common stock has also been assigned a new CUSIP number of 81689B103 Concurrently with the name change, Seneca has launched its new corporate website at www.senecabio.com. _________________ Neuralstem, Inc. (CUR) has announced a 1-for-20 reverse stock split. As a result of the reverse stock split, each CUR Common Share will be converted into the right to receive 0.05 (New) Neuralstem, Inc. Common Shares. The reverse stock split will become effective before the market open on July 18, 2019. The CUSIP number will change to 64127R500. ________________ January 9, 2017 -- Neuralstem, Inc. (CUR) will effect a one-for-thirteen (1-13) reverse split of its common stock. The CUSIP number will change to 64127R401.